《沪深两市》上证跌近2%深成挫0.6% 金融股弱 券商续炒
人行今无逆回购操作,人汇偏软,上证深成双双低开後反覆走个别,上证午後跌幅更扩大至一度逾2%。上证全日跌67点或1.95%,收报3,383点;深成跌83点或0.6%,收报13,671点;沪深300指数跌87点或1.8%,收报4,753点;沪深300指数下跌87点或1.8%,报4,753点;创业板指数则升20点或0.8%,报2,778点。沪深两市成交分别为7,032亿元人民币(下同)及9,093亿元。
中资金融股国寿(601628.SH)回吐7%。人保集团(601319.SH)第二大股东社保基金拟减持最多8.85亿股A股,股价挫7.4%。
银行股全线下跌,建行(601939.SH)跌4.4%。张家港行(002839.SZ)、青农商行(002958.SZ)、江阴银行(002807.SZ)、江苏银行(600919.SH)跌4.4%-6.9%。
券商股逆市炒上,中银证券(601696.SH)涨停。浙商证券(601878.SH)涨8.3%。华创阳安(600155.SH)、天风证券(601162.SH)、南京证券(601990.SH)升1.7%-6.7%。
车联网概念、汽车整车股受国策带动造好,中科创达(300496.SZ)、江淮汽车(600418.SH)涨停。中国重汽(000951.SZ)、长城汽车(601633.SH)、比亚迪(002594.SZ)升2.4%-5.6%。中银保监发布实施车险综合改革指导意见,预定附加费用率降至25%。
环球疫情仍然严峻,疫苗股上升,达安基因(002030.SZ)、辽宁成大(600739.SH)涨停,康泰生物(300601.SZ)、沃森生物(300142.SZ)、智飞生物(300122. SZ)升6.4%-7.2%。
五粮液(000858.SZ)高见211.8元再创新高,股价全日升1.6%报207元,市值突破8,000亿元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.